9-130693813-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014285.7(EXOSC2):āc.22C>Gā(p.Pro8Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00891 in 1,609,186 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0073 ( 10 hom., cov: 32)
Exomes š: 0.0091 ( 69 hom. )
Consequence
EXOSC2
NM_014285.7 missense
NM_014285.7 missense
Scores
4
14
Clinical Significance
Conservation
PhyloP100: 3.85
Genes affected
EXOSC2 (HGNC:17097): (exosome component 2) Predicted to enable RNA binding activity. Involved in positive regulation of cell growth. Located in cytoplasm; nucleolus; and nucleoplasm. Part of nuclear exosome (RNase complex). [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0038621426).
BP6
Variant 9-130693813-C-G is Benign according to our data. Variant chr9-130693813-C-G is described in ClinVar as [Benign]. Clinvar id is 778382.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00733 (1115/152170) while in subpopulation AMR AF= 0.0169 (258/15256). AF 95% confidence interval is 0.0152. There are 10 homozygotes in gnomad4. There are 550 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXOSC2 | NM_014285.7 | c.22C>G | p.Pro8Ala | missense_variant | 1/9 | ENST00000372358.10 | NP_055100.2 | |
EXOSC2 | NM_001282708.1 | c.22C>G | p.Pro8Ala | missense_variant | 1/8 | NP_001269637.1 | ||
EXOSC2 | NM_001282709.1 | c.22C>G | p.Pro8Ala | missense_variant | 1/8 | NP_001269638.1 | ||
EXOSC2 | NR_104230.1 | n.54C>G | non_coding_transcript_exon_variant | 1/8 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00734 AC: 1116AN: 152052Hom.: 10 Cov.: 32
GnomAD3 genomes
AF:
AC:
1116
AN:
152052
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00707 AC: 1745AN: 246954Hom.: 13 AF XY: 0.00712 AC XY: 957AN XY: 134324
GnomAD3 exomes
AF:
AC:
1745
AN:
246954
Hom.:
AF XY:
AC XY:
957
AN XY:
134324
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00907 AC: 13215AN: 1457016Hom.: 69 Cov.: 33 AF XY: 0.00867 AC XY: 6286AN XY: 725006
GnomAD4 exome
AF:
AC:
13215
AN:
1457016
Hom.:
Cov.:
33
AF XY:
AC XY:
6286
AN XY:
725006
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00733 AC: 1115AN: 152170Hom.: 10 Cov.: 32 AF XY: 0.00739 AC XY: 550AN XY: 74398
GnomAD4 genome
AF:
AC:
1115
AN:
152170
Hom.:
Cov.:
32
AF XY:
AC XY:
550
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
38
ALSPAC
AF:
AC:
39
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
77
ExAC
AF:
AC:
776
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | EXOSC2: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;M;.;M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T;T
Sift4G
Benign
T;T;T;T;T
Polyphen
B;.;.;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at